Arcus Biosciences Inc (NYSE:RCUS)
$ 15.27 -0.56 (-3.54%) Market Cap: 1.40 Bil Enterprise Value: 417.63 Mil PE Ratio: 0 PB Ratio: 2.47 GF Score: 79/100

Arcus Biosciences Inc at Citi BioPharma Conference (Virtual) Transcript

Sep 09, 2020 / 05:30PM GMT
Release Date Price: $21.76 (+5.07%)
Yigal Dov Nochomovitz
Citigroup Inc., Research Division - Director

Okay. I think we're in the main session. So welcome, everyone, to the fireside chat, or I should say, virtual fireside chat with Terry Rosen, the CEO of Arcus. Welcome, Terry.

As a reminder, I'm Yigal Nochomovitz. I'm one of the biotech analysts here at Citi. If you have questions for Terry during the course of the conversation, the easiest thing is just to e-mail me at [email protected]. And I also believe there's a way to post questions through the showcase feature on the video system. So you can do that either way.

Questions & Answers

Yigal Dov Nochomovitz
Citigroup Inc., Research Division - Director

So Terry, great to have you. Thank you so much for taking the time. And maybe we could just do this, just to start out, for those less familiar with Arcus, could you just do maybe a 2- to 3-minute high-level overview of the key assets in your pipeline?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot